|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-8-19
|
|
pubmed:abstractText |
Children under 6 yr have the highest incidence of severe hypoglycemia (SH) and the greatest likelihood of brain damage from SH. The purpose of this study is to evaluate the use of insulin glargine (Lantus in children under age 6 with type 1 diabetes (T1D).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1399-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
150-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16109071-Body Mass Index,
pubmed-meshheading:16109071-Child, Preschool,
pubmed-meshheading:16109071-Female,
pubmed-meshheading:16109071-Hemoglobin A, Glycosylated,
pubmed-meshheading:16109071-Humans,
pubmed-meshheading:16109071-Hypoglycemia,
pubmed-meshheading:16109071-Insulin,
pubmed-meshheading:16109071-Insulin, Long-Acting,
pubmed-meshheading:16109071-Male,
pubmed-meshheading:16109071-Quality of Life
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Use of insulin glargine in children under age 6 with type 1 diabetes.
|
|
pubmed:affiliation |
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|
